The product has been supplied without being included on the Australian Register of Therapeutic Goods. The product also contains Yohimbine, a substance not approved for supply in Australia.
Recall letters were despatched on 3 April 2002.
Print media advertisements will appear in the NSW & VIC print media on 4 April 2002, advising customers to return the product to point of purchase for a refund.
Classification system:
Class I defects are potentially life-threatening or could cause a serious risk to health.
Class II defects could cause illness or mistreatment, but are not Class I.
Class III defects may not pose a significant hazard to health, but withdrawal may be initiated for other reasons.
Class I & II recalls are considered to be safety related recalls.
